References

1. 1.
   LIU C，XIAO K，XIE L.Advances in the use of exosomes for the treatment of ALI/ARDS［J］.Front Immunol，2022，13：971189.
2. 2.
   ZHANG J，GUO Y，MAK M，et al.Translational medicine for acute lung injury［J］.J Transl Med，2024，22（1）：25.
3. 3.
   MOWERY N T，TERZIAN W，NELSON A C.Acute lung injury［J］.Curr Probl Surg，2020，57（5）：100777.
4. 4.
   WANG K，MA Y，KE J，et al.Study on the law of nature and flavor of Shengjiang San and Qingwen Baidu Yin based on data mining［J］.Shanghai Med Pharm J，2023，44（3）：75-79.
5. 5.
   YANG Q H，LI C，YANG Z Y.Study on the formula design and preparation technology of Qingwen Baidu granule［J］.Mod Chem Res，2023，7：149-151.
6. 6.
   YANG J，ZHANG Z，WANG J W，et al.Ameliorative effect and mechanism of Qingwen Baiduyin on lipopolysaccharide-induced acute lung injury［J］.Chin J Exp Tradit Med Form，2023，29（15）：1-13.
7. 7.
   SHEN W Y，WANG F，XU W，et al.Qingwen Baidu Yin ancient and modern use［J］.Heilongjiang J Tradit Chin Med，2012，41（6）：4-5.
8. 8.
   XU A P，HE X L，YOU S.Clinical observation of Qingwen Baidu decoction on sepsis-associated acute respiratory distress syndrome［J］.Hebei J Tradit Chin Med，2024，46（6）：932-935.
9. 9.
   XU S S，TANG Y，ZHAO E Y，et al.Clinical observation of Qingwen Baidu decoction in the treatment of lobar pneumonia in children［J］.Yunnan J Tradit Chin Med Mater Medica，2022，43（5）：47-50.
10. 10.
    GUO L L.Effect of modified Qingwen Baidu decoction combined with CRRT in the treatment of sepsis complicated with severe pneumonia with phlegm toxin accumulation in the lung syndrome［J］.Chin Foreign Med Res，2024，22（5）：31-35.
11. 11.
    LIAO Y，NIE S，XIAO C Y，et al.Clinical study on Qingwen BaiduYin combined with blood purification on sepsis with ARDS［J］.Asia-Pacific Tradit Med，2022，18（3）：85-89.
12. 12.
    YUAN X H，MO Y J，GUO X P.Clinical Study of Qingwen Baidu decoction compound in the treatment of community-acquired pneumonia［J］.Electr J Clin Med Lit，2020，7（8）：172-172.
13. 13.
    NIE L H，ZHANG Y T，WANG M，et al.Qingwenbaidu decoction used for curing mild cases of community acquired pneumonia［J］.Beijing Univ Tradit Chin Med，2010，17（2）：15-17.
14. 14.
    TIAN Y Z，WANG D Y，LIU S L，et al.Qingwen Baidu decoction combined with Tanreqing injection in the treatment of viral pneumonia caused by influenza A virus subtype H1N1［J］.Chin J Clin，2019，32（2）：260-263.
15. 15.
    JIANG D，ZHUO Q Y，CHEN X M，et al.Enlightenment of diagnosis and treatment of SARS in Beijing and Guangzhou［J］.Lishizhen Med Mater Med Res，2017，28（5）：1167-1169.
16. 16.
    WANG G Q，LI S，CHAO X，et al.Intervention of Qingwen Baidu decoction on p38MAPK and JAK2/STAT3 signaling pathway in rats with acute lung injury caused by sepsis［J］.Acta Chin Med，2018，33（11）：2076-2082.
17. 17.
    WANG G Q，LI S，Lin J，et al.Effect of Qingwen Baidu decoction on JAK2/STAT3 signaling pathway and its negative feedback mechanism in rats with sepsis induced acute lung injury［J］.Pharmacol Clin Chin Mater Med，2018，34（4）：7-11.
18. 18.
    JIA B T，WU Y L，LIAO J B，et al.Effects of Qingwen Baidu decoction on coagulation and multiple organ injury in rat models of sepsis［J］.Tradit Med Res，2022，7（3）：25.
19. 19.
    JI S X，WAN T J，LI B X，et al.Effects of Qingwen Baidu decoction on rats with viral pneumonia based on Th1/Th2 balance［J］.China J Tradit Chin Med Pharm，2022，37（9）：5400-5404.
20. 20.
    WANG X，YANG Y P.Studies on antipyretic，anti-inflammatory and antibacterial effects of Qingwenbaidu Mixture［J］.Front Med，2014，（13）：110-111.
21. 21.
    WU W，LIN H，YIN A，et al.GC‐MS based metabolomics reveals the synergistic mechanism of Gardeniae Fructus‐Forsythiae Fructus herb pair in lipopolysaccharide‐induced acute lung injury mouse model［J］.Evid-Based Compl Alt，2021，2021（1）：8064557.
22. 22.
    TANG Y，SHI C，SUN L，et al.Herb pair of Glycyrrhiza Radix-Platycodonis Radix alleviates respiratory syncytial virus pneumonia in mice by modulating lipid metabolism and inhibiting inflammation［J］.World J Tradit Chin Med，2024，10（3）：322-333.
23. 23.
    GUO S J.Preparation of Qingwen Baidu Keli and study of pharmacology［D］.Changchun：Jilin University，2012.
24. 24.
    ZHANG Q，LEI H M，WANG P L，et al.Bioactive components from Qingwen Baidu decoction against LPS-induced acute lung injury in rats［J］.Molecules，2017，22（5）：692.
25. 25.
    WANG F，HE S D，ZHANG C Z，et al.Study on the protective effect of Qingwen Baidu decoction on acute lung injury in rats ［J］.Chin J Tradit Med Sci Technol，2013，20（2）：117-118.
26. 26.
    HE Y L，MAO X Z，LI S，et al.Study on the mechanism of Qingwen Baidu decoction in the treatment of sepsis acute lung injury based on network pharmacology ［J］.Pharmacol Clin Chin Mater Med，2022，38（6）：13-20.
27. 27.
    ZHENG Y，LIU S，FAN C，et al.Holistic quality evaluation of Qingwen Baidu decoction and its anti-inflammatory effects［J］.J Ethnopharmacol，2020，263：113145.
28. 28.
    ESQUIVEL-RUIZ S，GONZÁLEZ-RODRÍGUEZ P，LORENTE J A，et al.Extracellular vesicles and alveolar epithelial-capillary barrier disruption in acute respiratory distress syndrome：Pathophysiological role and therapeutic potential［J］.Front Physiol，2021，12：752287.
29. 29.
    LU Z B，LIU S H，OU J Y，et al.Corrigendum to "Forsythoside A inhibits adhesion and migration of monocytes to type Ⅱ alveolar epithelial cells in lipopolysaccharide-induced acute lung injury through upregulating miR-124"［J］.Toxicol Appl Pharmacol，2020，409：115328.
30. 30.
    CHEN X，CHEN J，REN Y，et al.β-sitosterol enhances lung epithelial cell permeability by suppressing the NF-κB signaling pathway［J］.Discov Med，2023，35（179）：946-955.
31. 31.
    DENG S，LI J，LI L，et al.Quercetin alleviates lipopolysaccharide‑induced acute lung injury by inhibiting ferroptosis via the Sirt1/Nrf2/GPX4 pathway［J］.Int J Mol Med，2023，52（6）：1-15.
32. 32.
    HOU Y，LI J，DING Y，et al.Luteolin attenuates lipopolysaccharide-induced acute lung injury/acute respiratory distress syndrome by activating alveolar epithelial sodium channels via cGMP/PI3K pathway［J］.J Ethnopharmacol，2022，282：114654.
33. 33.
    GAO M，ZHU X，GAO X，et al.Kaempferol mitigates sepsis-induced acute lung injury by modulating the SphK1/S1P/S1PR1/MLC2 signaling pathway to restore the integrity of the pulmonary endothelial cell barrier［J］.Chem Biol Interact，2024，398：111085.
34. 34.
    KUMAR V.Pulmonary innate immune response determines the outcome of inflammation during pneumonia and sepsis-associated acute lung injury［J］.Front Immunol，2020，11：1722.
35. 35.
    CHEN J，HUANG Y，BIAN X，et al.Berberine ameliorates inflammation in acute lung injury via NF-κB/NLRP3 signaling pathway［J］.Front Nutr，2022，9：851255.
36. 36.
    LI N，XIONG R，HE R，et al.Mangiferin mitigates lipopolysaccharide-induced lung injury by inhibiting NLRP3 inflammasome activation［J］.J Inflamm Res，2021，（14）：2289-2300.
37. 37.
    MIAO J，ZHONG J，LAN J，et al.Paeonol attenuates inflammation by confining HMGB1 to the nucleus［J］.J Cell Mol Med，2021，25（6）：2885-2899.
38. 38.
    TANG H，YANG D，ZHU L，et al.Paeonol interferes with quorum-sensing in pseudomonas aeruginosa and modulates inflammatory responses in vitro and in vivo［J］.Front Immunol，2022，13：896874.
39. 39.
    ZHOU H，YANG T，LU Z，et al.Liquiritin exhibits anti-acute lung injury activities through suppressing the JNK/Nur77/c-Jun pathway［J］.Chin Med，2023，18（1）：35.
40. 40.
    CHEN Y，QU L，LI Y，et al.Glycyrrhizic acid alleviates lipopolysaccharide（LPS）-induced acute lung injury by regulating angiotensin-converting enzyme-2（ACE2） and caveolin-1 signaling pathway［J］.Inflammation，2022，45（1）：253-266.
41. 41.
    WANG K，ZHANG Y，CAO Y，et al.Glycyrrhetinic acid alleviates acute lung injury by PI3K/Akt suppressing macrophagic NLRP3 inflammasome activation［J］.Biochem Biophys Res Commun，2020，532（4）：555-562.
42. 42.
    YU X，CHEN D，WANG L，et al.Wogonoside inhibits inflammatory cytokine production in lipopolysaccharide-stimulated macrophage by suppressing the activation of the JNK/c-Jun signaling pathway［J］.Ann Transl Med，2020，8（8）：532.
43. 43.
    GE J，YANG H，YU N，et al.Wogonin alleviates sepsis-induced acute lung injury by modulating macrophage polarization through the SIRT1-FoxO1 pathways［J］.Tissue Cell，2024，88：102400.
44. 44.
    SUL O J，RA S W.Quercetin prevents LPS-induced oxidative stress and inflammation by modulating NOX2/ROS/NF-κB in lung epithelial cells［J］.Molecules，2021，26（22）：6949.
45. 45.
    CHEN L，SONG C，ZHANG Y，et al.Quercetin protects against LPS-induced lung injury in mice via SIRT1-mediated suppression of PKM2 nuclear accumulation［J］.Eur J Pharmacol，2022，936：175352.
46. 46.
    SHEN B，ZHANG H，ZHU Z，et al.Baicalin relieves LPS-induced lung inflammation via the NF-κB and MAPK pathways［J］.Molecules，2023，28（4）：1873.
47. 47.
    CHANGLE Z H U，CUILING F，FENG F，et al.Baicalin inhibits inflammation of lipopolysaccharide-induced acute lung injury via toll like receptor-4/myeloid differentiation primary response 88/nuclear factor-kappa B signaling pathway［J］.J Tradit Chin Med，2022，42（2）：200.
48. 48.
    YANG Q，YUE C，HUANG X，et al.Functional mechanism of baicalein in alleviating severe acute pancreatitis-acute lung injury by blocking the TLR4/MyD88/TRIF signaling pathway［J］.Histol Histopathol，2024，39（10）：1381-1394.
49. 49.
    JIANG C，ZHANG J，XIE H，et al.Baicalein suppresses lipopolysaccharide-induced acute lung injury by regulating Drp1-dependent mitochondrial fission of macrophages［J］.Biomed Pharmacother，2022，145：112408.
50. 50.
    XIAO Y，ZHANG B，HOU S，et al.Acacetin attenuates sepsis-induced acute lung injury via NLRC3-NF-κB pathway［J］.Inflammation，2025，48（1）：75-88.
51. 51.
    CHANG B，WANG Z，CHENG H，et al.Acacetin protects against sepsis-induced acute lung injury by facilitating M2 macrophage polarization via TRAF6/NF-κB/COX2 axis［J］.Innate Immun，2024，30（1）：11-20.
52. 52.
    FU H，ZHU H.Geniposidic acid protects lipopolysaccharide-induced acute lung injury via the TLR4/MyD88 signaling pathway in vitro and in vivo［J］.Immunopharmacol Immunotoxicol，2022，44（6）：984-992.
53. 53.
    WANG J，XIN L，WANG H，et al.Forsythiaside A alleviates acute lung injury via the RNF99/TRAF6/NF-κB signaling pathway［J］.Int Immunopharmacol，2024，140：112814.
54. 54.
    CHEN S，BAI Y，XIA J，et al.Rutin alleviates ventilator-induced lung injury by inhibiting NLRP3 inflammasome activation［J］.iScience，2023，26（10）：107866.
55. 55.
    GUO J，LIU Q Z，ZHU F J，et al.Acteoside attenuates acute lung injury following administration of cobra venom factor to mice［J］.Heliyon，2022，8（11）：e11622.
56. 56.
    YU W，ZENG M，XU P，et al.Effect of paeoniflorin on acute lung injury induced by influenza A virus in mice.Evidences of its mechanism of action［J］.Phytomedicine，2021，92：153724.
57. 57.
    ZHOU B X，LI J，LIANG X L，et al.β-sitosterol ameliorates influenza A virus-induced proinflammatory response and acute lung injury in mice by disrupting the cross-talk between RIG-I and IFN/STAT signaling［J］.Acta Pharmacol Sin，2020，41（9）：1178-1196.
58. 58.
    LIU Y，WANG X，CHEN Y，et al.Pharmacological mechanisms of traditional Chinese medicine against acute lung injury：From active ingredients to herbal formulae［J］.Phytomedicine，2024，135：155562.
59. 59.
    GUO P，JIN L，ZHOU H，et al.Glycyrrhetinic acid protects against Multidrug-resistant Acinetobacter baumannii-induced lung epithelial cells injury by regulating inflammation and oxidative stress［J］.BMC Pharmacol Toxicol，2023，24（1）：5.
60. 60.
    SANG A，WANG Y，WANG S，et al.Quercetin attenuates sepsis-induced acute lung injury via suppressing oxidative stress-mediated ER stress through activation of SIRT1/AMPK pathways［J］.Cell Signal，2022，96：110363.
61. 61.
    DA SILVA ARAÚJO N P ，DE MATOS N A，LETICIA ANTUNES MOTA S，et al.Quercetin attenuates acute lung injury caused by cigarette smoke both in vitro and in vivo［J］.COPD，2020，17（2）：205-214.
62. 62.
    SPAMPINATO M，CAROTA G，SFERRAZZO G，et al.Effects of mangiferin on LPS-induced inflammation and SARS-CoV-2 viral adsorption in human lung cells［J］.Pharmaceutics，2022，14（12）：2845.
63. 63.
    ZHENG J N，ZHUO J Y，NIE J，et al.Phenylethanoid glycosides from Callicarpa kwangtungensis Chun attenuate TNF-α-induced cell damage by inhibiting NF-κB pathway and enhancing Nrf2 pathway in A549 cells［J］.Front Pharmacol，2021，12：693983.
64. 64.
    CHENG X，HU R C，LUO J H，et al.Therapeutic effect and mechanism of paeoniflorin on scald injuries in rats based on network pharmacology［J］.World Chin Med，2024，19（16）：2371-2377.
65. 65.
    FAN G H，ZHU T Y，WANG R，et al.Oxypaeoniflorin prevents acute lung injury induced by lipopolysaccharide through the PTEN/Akt pathway in a Sirt1‐dependent manner［J］.Oxid Med Cell Longev，2021，2021（1）：6878026.
66. 66.
    MATUTE-BELLO G，MARTIN T R.Science review：Apoptosis in acute lung injury［J］.Crit Care，2003，7（5）：355-358..
67. 67.
    GE J，YANG H，ZENG Y，et al.Protective effects of wogonin on lipopolysaccharide-induced inflammation and apoptosis of lung epithelial cells and its possible mechanisms［J］.Biomed Eng Online，2021，20（1）：125.
68. 68.
    ZHANG Y，ZHANG J，REN Y，et al.Luteolin suppresses sepsis-induced cold-inducible RNA-binding protein production and lung injury in neonatal mice［J］.Shock，2021，55（2）：268-273.
69. 69.
    YANG C，YANG W，HE Z，et al.Kaempferol alleviates oxidative stress and apoptosis through mitochondria-dependent pathway during lung ischemia-reperfusion injury［J］.Front Pharmacol，2021，12：624402.
70. 70.
    LING X，ZHOU J，JIN T，et al.Acteoside attenuates RSV-induced lung injury by suppressing necroptosis and regulating metabolism［J］.Front Pharmacol，2022，13：870928.
71. 71.
    CHEN X，HUANG J.Mangiferin inhibits hypoxia/reoxygenation-induced alveolar epithelial cell injury via the SIRT1/AMPK signaling pathway［J］.Exp Ther Med，2021，22（5）：1220.
72. 72.
    GENG P，ZHU H，ZHOU W，et al.Baicalin inhibits influenza A virus infection via promotion of M1 macrophage polarization［J］.Front Pharmacol，2020，11：01298.
73. 73.
    QI H，MA Q H，FENG W，et al.Glycyrrhetinic acid blocks SARS-CoV-2 infection by activating the cGAS-STING signalling pathway［J］.Br J Pharmacol，2024，181（20）：3976-3992.
74. 74.
    SAVIN I A，ZENKOVA M A，SEN'KOVA A V.Pulmonary fibrosis as a result of acute lung inflammation：Molecular mechanisms，relevant in vivo models，prognostic and therapeutic approaches［J］.Int J Mol Sci，2022，23（23）：14959.
75. 75.
    WEI Y，LIU C，LI L.Geniposide improves bleomycin-induced pulmonary fibrosis by inhibiting NLRP3 inflammasome activation and modulating metabolism［J］.J Funct Foods，2023，104：105503.
76. 76.
    SHARMA D K，SINGH N D，LEISHANGTHEM G D，et al.Amelioration of bleomycin-induced acute lung injury and epithelial-mesenchymal transition by baicalein in mice［J］.Curr Sci，2020，119（6）：962-972.
77. 77.
    NASSEF N A A，ABD-EL HAMID M S，ABUSIKKIEN S A，et al.Quercetin ameliorates acute lung injury in a rat model of hepatopulmonary syndrome［J］.BMC Complement Med Ther，，2022，22（1）：320.
78. 78.
    YIGIT E，YIGIT M H，ATAK M，et al.Kaempferol reduces pyroptosis in acute lung injury by decreasing ADAM10 activity through the NLRP3/GSDMD pathway［J］.Food Biosci，2024，62：105140.
79. 79.
    ZHANG Z T，ZHANG D Y，XIE K，et al.Luteolin activates Tregs to promote IL-10 expression and alleviating Caspase-11-dependent pyroptosis in sepsis-induced lung injury［J］.Int Immunopharmacol，2021，99：107914.
80. 80.
    CHEN L W，LIU X Y，WANG X Y，et al.Berberine alleviates acute lung injury in septic mice by modulating Treg/Th17 homeostasis and downregulating NF-κB signaling［J］.Drug Des Devel Ther，2023，（17）：1139-1151.
81. 81.
    LIU Z，GAO J L，BAN Y，et al.Synergistic effect of paeoniflorin combined with luteolin in alleviating lipopolysaccharides-induced acute lung injury［J］.J Ethnopharmacol，2024，327：118022.
82. 82.
    ZHANG Q，NIE J，CHEN S J，et al.Protective effects of ethyl gallate and pentagalloylglucose，the active components of Qingwen Baidu decoction，against lipopolysaccharide-induced acute lung injury in rats［J］.Drug Des Devel Ther，2019，13：71-77.
83. 83.
    LONG Y，XIANG Y，LIU S，et al.Baicalin liposome alleviates lipopolysaccharide-induced acute lung injury in mice via Inhibiting TLR4/JNK/ERK/NF-κB pathway［J］.Mediators Inflamm，2020，2020：8414062.
84. 84.
    CHEN Y B，ZHANG Y B，WANG Y L，et al.A novel inhalable quercetin-alginate nanogel as a promising therapy for acute lung injury［J］.J Nanobiotechnology，2022，20（1）：272.
85. 85.
    LI H，ZHU J，WANG C，et al.Paeonol loaded cyclodextrin metal-organic framework particles for treatment of acute lung injury via inhalation［J］.Int J Pharm，2020，587：119649.
86. 86.
    XUE L.Current situation and future of treatment strategies for acute lung injury ［J］.Shanghai Med J，2021，44（8）：571-575.
87. 87.
    SU J S，LIU E S，ZHAO X M.Advances in the treatment of acute lung injury/acute respiratory distress syndrome with traditional Chinese medicine［J］.Jilin J Tradit Chin Med，2019，39（5）：696-700.